Paper Details

  1. Home
  2. Paper Details

Isolation and characterization of hepatitis C virus resistant to a novel phenanthridinone derivative.

Author: BabaMasanori, HashimotoYuichi, IkedaMasanori, ItoWataru, OkamotoMika, ToyamaMasaaki, WakitaTakaji, WatashiKoichi

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

HA-719, a novel phenanthridinone derivative, inhibits hepatitis C virus (HCV) replication. Analysis of a HA-719-resistant replicon clone revealed mutations in the NS5B polymerase that were not previously associated with resistance to other HCV drugs. This suggests that HA-719 targets a different site than existing HCV drugs.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The novel phenanthridinone derivative HA-719 has recently been identified as a highly potent and selective inhibitor of hepatitis C virus replication. To elucidate its mechanism of inhibition, we have isolated and analyzed a clone of hepatitis C virus replicon cells resistant to HA-719. ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890506/

データ提供：米国国立医学図書館（NLM）

Unmasking Hepatitis C Virus Resistance: A Novel Phenanthridinone Derivative Faces a Challenge

This research investigates the mechanism of action of a novel phenanthridinone derivative, HA-719, a potent inhibitor of hepatitis C virus (HCV) replication. The authors isolated an HCV replicon cell clone resistant to HA-719, revealing mutations in the viral genome that confer resistance. This study provides valuable insights into the mechanisms of HCV resistance, guiding the development of new antiviral agents with improved efficacy.

A Battle of Wits: The Virus Strikes Back

This research illuminates the complex interplay between antiviral therapies and the evolving nature of viruses. The authors' findings highlight the importance of understanding viral resistance mechanisms to develop new antiviral agents that can overcome these challenges.

The Constant Quest for New Therapies: A Race Against the Virus

This study underscores the ongoing race to develop new antiviral therapies that can effectively combat the ever-evolving threat of HCV. The authors' findings provide crucial insights into the mechanisms of viral resistance, informing the development of next-generation antiviral agents.

Dr. Camel's Conclusion

This research unveils the cunning strategies employed by HCV to evade antiviral therapies. It's like a game of hide-and-seek in the vast desert of viral evolution, where researchers are constantly on the lookout for new ways to outsmart the virus and develop effective treatments for this debilitating disease.

Date :
  1. Date Completed 2019-04-29
  2. Date Revised 2019-04-29
Further Info :

Pubmed ID

27503576

DOI: Digital Object Identifier

PMC5890506

Related Literature

Article Analysis
・Effects of telaprevir
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.